SunHydrogen

SunHydrogen

SunHydrogen was founded in 2009 and operates from Santa Barbara, California, where CEO Tim Young and Chief Scientific Officer Syed Mubeen oversee its technology roadmap. Originally incorporated as HyperSolar, the firm pivoted to focus entirely on a single innovation: a nanoparticle device that splits water molecules into hydrogen and oxygen when submerged in sunlight. Public record shows the company shifted its corporate name to SunHydrogen in 2021 to place its core mission at the center of its identity. The company pursues a direct-technology development strategy centered on nanoparticle-based photoelectrochemical water splitting. Unlike conventional green hydrogen production, which pairs a solar farm with a separate electrolyzer system, SunHydrogen designs its hydrogen-generating panels to function independently without an external electrolyzer. The firm outsources key manufacturing steps: in 2023, it announced a partnership with COTEC of South Korea to industrialize and scale the electroplating of its semiconductor units, and it has contracted with the University of Iowa and the University of Michigan for fundamental materials-science research. De-risking efforts in 2024 included demonstrating a 1m² proof-of-concept panel that generated hydrogen in real-world, sub-freezing conditions in Canada (per SolarPACES, 2024). The geographic footprint extends from its California lab to manufacturing partners in South Korea and field-testing sites in North America. Team size remains undisclosed; SunHydrogen maintains a lean workforce amplified by university research collaborations and contracted engineering firms. Beyond its core Oregon-based lab and Santa Barbara headquarters, no additional company-owned offices are publicly listed. The firm does not manage a venture portfolio or external investment pool — research and development is funded through equity raises on the OTC market. A defining operational event came in October 2023, when SunHydrogen moved into commercial-scale manufacturing exploration by signing a Master Agreement with COTEC, a Korean deposition-technology specialist, to advance electroplating processes for its hydrogen panel components (per the firm, October 2023). SunHydrogen's structural distinction lies in its public listing as an early-stage, pre-revenue technology developer rather than a fund or family office. Markets, not limited partners, serve as its capital source. The scientific integrity of its approach is tied to the academic relationships it has formed, making it a rare entity where public shareholders fund fundamental research normally conducted within university labs. Succession and commercialization depend entirely on the nanoparticle panel achieving cost-per-kilogram parity with established electrolyzer systems, a milestone not yet demonstrated at scale.